BACKGROUND: Effective diabetes management requires a multimodal approach involving lifestyle changes, pharmacological treatment, and continuous patient education. Self-management demands can be overwhelming for patients, leading to lowered motivation, poor adherence, and compromised therapeutic outcomes. In this context, digital health apps are emerging as vital tools to provide personalized support and enhance diabetes management and clinical outcomes. OBJECTIVE: This study evaluated the impact of the digital health application Vitadio on glycemic control in patients with type 2 diabetes mellitus (T2DM). Secondary objectives included evaluating its effects on cardiometabolic parameters (weight, BMI, waist circumference, blood pressure, and heart rate) and self-reported measures of diabetes distress and self-management. METHODS: In this 6-month, 2-arm, multicenter, unblinded randomized controlled trial, patients aged 18 years or older diagnosed with T2DM were randomly assigned (1:1) to an intervention group (IG) receiving standard diabetes care reinforced by the digital health app Vitadio or to a control group (CG) provided solely with standard diabetes care. Vitadio provided a mobile-based self-management support tool featuring educational modules, motivational messages, peer support, personalized goal setting, and health monitoring. The personal consultant was available in the app to provide technical support for app-related issues. The primary outcome, assessed in the intention-to-treat population, was a change in glycated hemoglobin (HbA1c) levels at 6 months. Secondary outcomes included changes in cardiometabolic measures and self-reported outcomes. Data were collected in 2 study centers: diabetologist practice in Dessau-Roßlau and the University of Dresden. RESULTS: Between November 2022 and June 2023, a total of 276 patients were screened for eligibility, with 149 randomized to in intervention group (IG; n=73) and a control group (CG; n=76). The majority of participants were male (91/149, 61%). The dropout rate at month 6 was 19% (121/149). While both groups achieved significant HbA1c reduction at 6 months (IG: mean -0.8, SD 0.9%, P<.001; CG: mean -0.3, SD 0.7%, P=.001), the primary confirmatory analysis revealed statistically significant advantage of the IG (adjusted mean difference: -0.53%, SD 0.15, 95% CI -0.24 to -0.82; P<.001; effect size [Cohen d]=0.67, 95% CI 0.33-1). Significant between-group differences in favor of the IG were also observed for weight loss (P=.002), BMI (P=.001) and systolic blood pressure (P<.03). In addition, Vitadio users experienced greater reduction in diabetes-related distress (P<.03) and obtained more pronounced improvements in self-care practices in the areas of general diet (P<.001), specific diet (P<.03), and exercise (P<.03). CONCLUSIONS: This trial provides evidence for the superior efficacy of Vitadio in lowering the HbA1c levels in T2DM patients compared to standard care. In addition, Vitadio contributed to improvements in cardiometabolic health, reduced diabetes-related distress, and enhanced self-management, highlighting its potential as an accessible digital tool for comprehensive diabetes management. TRIAL REGISTRATION: German Clinical Trials Registry DRKS00027405; https://drks.de/search/de/trial/DRKS00027405.

Department of Prevention and Care of Diabetes Department of Medicine 3 Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany

German Center for Diabetes Research Munich Germany

Paul Langerhans Institute Dresden Dresden Germany

Vitadio s r o Prague Czech Republic

Zobrazit více v PubMed

Jacobs E, Rathmann W. Epidemiologie des diabetes. Diabetologie und Stoffwechsel. 2017;12(06):437–446. doi: 10.1055/s-0043-120034. DOI

Tönnies T, Hoyer A, Brinks R, Kuss O, Hering R, Schulz M. Spatio-temporal trends in the incidence of type 2 diabetes in Germany. Dtsch Arztebl Int. 2023;120(11):173–179. doi: 10.3238/arztebl.m2022.0405. arztebl.m2022.0405 PubMed DOI PMC

Bain S, Cummings MH, McKay GA. Multidisciplinary approach to management and care of patients with type 2 diabetes mellitus. EMJ Diabet. 2019:73–81. doi: 10.33590/emjdiabet/10314374. DOI

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD) Diabetes Care. 2018;41(12):2669–2701. doi: 10.2337/dci18-0033. dci18-0033 PubMed DOI PMC

Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, Maryniuk MD, Siminerio L, Vivian E. Diabetes self-management education and support in type 2 diabetes: A joint position statement of the American diabetes association, the American association of diabetes educators, and the academy of nutrition and dietetics. Clin Diabetes. 2016;34(2):70–80. doi: 10.2337/diaclin.34.2.70. 70 PubMed DOI PMC

Carpenter R, DiChiacchio T, Barker K. Interventions for self-management of type 2 diabetes: an integrative review. Int J Nurs Sci. 2019;6(1):70–91. doi: 10.1016/j.ijnss.2018.12.002. S2352-0132(18)30342-9 PubMed DOI PMC

Cotter AP, Durant N, Agne AA, Cherrington AL. Internet interventions to support lifestyle modification for diabetes management: a systematic review of the evidence. J Diabetes Complications. 2014;28(2):243–251. doi: 10.1016/j.jdiacomp.2013.07.003. S1056-8727(13)00165-7 PubMed DOI PMC

Lambrinou E, Hansen TB, Beulens JW. Lifestyle factors, self-management and patient empowerment in diabetes care. Eur J Prev Cardiol. 2019;26(2_suppl):55–63. doi: 10.1177/2047487319885455. PubMed DOI

Raveendran AV, Chacko EC, Pappachan JM. Non-pharmacological treatment options in the management of diabetes mellitus. Eur Endocrinol. 2018;14(2):31–39. doi: 10.17925/EE.2018.14.2.31. PubMed DOI PMC

Sneha S, Thalla S, Rischie I, Shahriar H. Health internet technology for chronic conditions: review of diabetes management apps. JMIR Diabetes. 2021;6(3):e17431. doi: 10.2196/17431. v6i3e17431 PubMed DOI PMC

Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2017;34(11):1508–1520. doi: 10.1111/dme.13448. PubMed DOI

Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabet Med. 2005;22(10):1379–1385. doi: 10.1111/j.1464-5491.2005.01644.x.DME1644 PubMed DOI

Thoolen BJ, de Ridder D, Bensing J, Gorter K, Rutten G. Beyond good intentions: the role of proactive coping in achieving sustained behavioural change in the context of diabetes management. Psychol Health. 2009;24(3):237–254. doi: 10.1080/08870440701864504.791048222 PubMed DOI

Heise M, Heidemann C, Baumert J, Du Y, Frese T, Avetisyan M, Weise S. Structured diabetes self-management education and its association with perceived diabetes knowledge, information, and disease distress: Results of a nationwide population-based study. Prim Care Diabetes. 2022;16(3):387–394. doi: 10.1016/j.pcd.2022.03.016. S1751-9918(22)00077-8 PubMed DOI

Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–943. doi: 10.1016/j.pec.2015.11.003. S0738-3991(15)30116-6 PubMed DOI

Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018;6(2):130–142. doi: 10.1016/S2213-8587(17)30239-5.S2213-8587(17)30239-5 PubMed DOI

Fuchs S, Henschke C, Blümel M, Busse R. Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness. Dtsch Arztebl Int. 2014;111(26):453–463. doi: 10.3238/arztebl.2014.0453. arztebl.2014.0453 PubMed DOI PMC

Mehring M, Donnachie E, Bonke FC, Werner C, Schneider A. Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study. Diabetol Metab Syndr. 2017;9:37. doi: 10.1186/s13098-017-0236-y. 236 PubMed DOI PMC

Sönnichsen AC, Winkler H, Flamm M, Panisch S, Kowatsch P, Klima G, Fürthauer B, Weitgasser R. The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial. BMC Fam Pract. 2010;11:86. doi: 10.1186/1471-2296-11-86. 1471-2296-11-86 PubMed DOI PMC

Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015;17(2):e52. doi: 10.2196/jmir.3951. v17i2e52 PubMed DOI PMC

Lunde P, Nilsson BB, Bergland A, Kværner KJ, Bye A. The effectiveness of smartphone apps for lifestyle improvement in noncommunicable diseases: systematic review and meta-analyses. J Med Internet Res. 2018;20(5):e162. doi: 10.2196/jmir.9751. v20i5e162 PubMed DOI PMC

Hermanns N, Ehrmann D, Finke-Groene K, Kulzer B. Trends in diabetes self-management education: where are we coming from and where are we going? A narrative review. Diabet Med. 2020;37(3):436–447. doi: 10.1111/dme.14256. PubMed DOI

The fast-track process for digital health applications (DiGA) according to section 139e SGB V A guide for manufacturers, service providers and user 2020. BfArM. 2020. [2025-04-15]. https://www.bfarm.de/SharedDocs/Downloads/EN/MedicalDevices/DiGA_Guide.pdf?__blob=publicationFile .

Moravcová K, Karbanová M, Bretschneider MP, Sovová M, Ožana J, Sovová E. Comparing digital therapeutic intervention with an intensive obesity management program: randomized controlled trial. Nutrients. 2022;14(10):2005. doi: 10.3390/nu14102005. nu14102005 PubMed DOI PMC

Bretschneider MP, Klásek J, Karbanová M, Timpel P, Herrmann S, Schwarz PEH. Impact of a digital lifestyle intervention on diabetes self-management: A pilot study. Nutrients. 2022;14(9):1810. doi: 10.3390/nu14091810. nu14091810 PubMed DOI PMC

Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, Müller-Wieland D, Nauck MA, Reuter H, Siegel E. Therapy of type 2 diabetes. Exp Clin Endocrinol Diabetes. 2019;127(S 01):S73–S92. doi: 10.1055/a-1018-9106. PubMed DOI

American Diabetes Association 6. Glycemic Targets: Diabetes Care. 2021;44(Suppl 1):S73–S84. doi: 10.2337/dc21-S006.dc21-S006 PubMed DOI

Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, Müller-Wieland D, Nauck MA, Wiesner T, Siegel E. Therapy of type 2 diabetes. Exp Clin Endocrinol Diabetes. 2022;130(S 01):S80–S112. doi: 10.1055/a-1624-3449. PubMed DOI

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339. 5079119 PubMed DOI

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. Eur Heart J. 2020;41(2):231–238. doi: 10.1093/eurheartj/ehy808.5259364 PubMed DOI

Kamimura D, Tamura K. Resting heart rate as a possible biomarker and target to prevent future cardiovascular disease in type 2 diabetes patients (HTR-2023-0066.R2) Hypertens Res. 2023;46(5):1160–1162. doi: 10.1038/s41440-023-01251-9.10.1038/s41440-023-01251-9 PubMed DOI

Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301–1313. doi: 10.1161/CIRCULATIONAHA.111.067264.126/10/1301 PubMed DOI

Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–950. doi: 10.2337/diacare.23.7.943. PubMed DOI

Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. 2015;3(6):450–460. doi: 10.1016/S2213-8587(15)00135-7.S2213-8587(15)00135-7 PubMed DOI

Schrepp M. User Experience Questionnaire Handbook, Version 11, 2023. 2023. [2025-04-15]. https://www.ueq-online.org/

Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191. doi: 10.3758/bf03193146. PubMed DOI

Meyerowitz-Katz G, Ravi S, Arnolda L, Feng X, Maberly G, Astell-Burt T. Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis. J Med Internet Res. 2020;22(9):e20283. doi: 10.2196/20283. v22i9e20283 PubMed DOI PMC

Cro S, Morris TP, Kenward MG, Carpenter JR. Reference-based sensitivity analysis via multiple imputation for longitudinal trials with protocol deviation. Stata J. 2016;16(2):443–463. PubMed PMC

Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. doi: 10.1016/S0140-6736(15)01225-8.S0140-6736(15)01225-8 PubMed DOI

American Diabetes Association Professional Practice Committee 5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S60–S82. doi: 10.2337/dc22-S005.138923 PubMed DOI

Hoogendoorn CJ, Schechter CB, Llabre MM, Walker EA, Gonzalez JS. Distress and type 2 diabetes self-care: putting the pieces together. Ann Behav Med. 2021;55(10):938–948. doi: 10.1093/abm/kaaa070. 5904067 PubMed DOI PMC

Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med. 2019;34(2):320–324. doi: 10.1007/s11606-018-4705-2. 10.1007/s11606-018-4705-2 PubMed DOI PMC